INS and Hyperglycemia: Disrupted redox signaling also promotes pro-inflammatory and pro-fibrotic pathways, affecting insulin metabolic signaling and endothelial dysfunction, and promoting cardiovascular and renal inflammation and fibrosis (54, 55), which can lead to target organ damage and the emergence of major components of Mets, such as hyperglycemia and hypoglycemia.